Enorama Pharma AB is a Swedish pharmaceutical company listed on Nasdaq First North Growth Market. We focus on development and manufacturing of consumer friendly medicated chewing gums containing well proven generic substances.
Nicotine Pouches are available to consumers in US under its own brand NIC-S. Enorama’s nicotine gum is available in Europe only. Another business area, medical cannabis (CBD), is in an exciting phase of development.
Offering the opportunity to reduce, and eventually eliminate, individual tobacco use is a fundamental value as a financial driver for all parts of the company.